Omeprazole Biogaran

Omeprazole, the active ingredient in Omeprazole Biogaran, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production in adults with acid‑related disorders.

GNH USA supplies Omeprazole Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Biogaran belongs to the proton pump inhibitor class and is used to manage acid‑related gastrointestinal conditions. - Gastroesophageal reflux disease (GERD): provides symptomatic relief by lowering stomach acidity. - Peptic ulcer disease: promotes ulcer healing through acid suppression. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: discomfort in the upper abdomen. - Nausea: occasional feeling of queasiness. - Diarrhea: loose stools occurring intermittently. - Constipation: reduced bowel movements. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe allergic reactions: anaphylaxis, Stevens‑Johnson syndrome. - Clostridium difficile infection: colitis associated with antibiotic use. - Hypomagnesemia: low magnesium levels with prolonged therapy. - Liver enzyme elevation: increased ALT/AST. - Interstitial nephritis: inflammation of kidney tissue. - Bone fractures: increased risk with long‑term use.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged treatment may cause hypomagnesemia. - Avoid long‑term use without supervision: risk of fractures and nutrient deficiencies. - Use caution in liver disease: hepatic impairment may affect drug metabolism. - Review concomitant medications: potential for clinically significant interactions. - Store at room temperature: keep in the original container, protect from moisture.

Omeprazole Biogaran can affect the pharmacokinetics of several drugs. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - HIV protease inhibitors (e.g., ritonavir): altered metabolism leading to increased toxicity. Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations. - Methotrexate: heightened risk of toxicity. - Oral contraceptives: possible reduction in contraceptive effectiveness.